Jin Ping Lu
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 89
- Multiple Myeloma Research and Treatments 65
- Acute Myeloid Leukemia Research 10
- Platelet Disorders and Treatments 8
- Genetics 20
- Chronic Lymphocytic Leukemia Research 12
- Co-authors
- Xiao‐Jun Huang (61 shared papers)Qian Jiang (16 shared papers)Jian Hou (6 shared papers)Qing Ge (9 shared papers)Wei Chen (1 shared paper)Meng Lv (2 shared papers)Tao Jiang (1 shared paper)Hao Jiang (13 shared papers)
- Journals
- Blood (12 papers)Annals of Hematology (6 papers)Frontiers in Oncology (6 papers)BMC Cancer (4 papers)Leukemia (3 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Jin Ping Lu
162 papers receiving 3.2k citations
Jin Ping Lu's Hit Papers
Peers
Comparison fields: 5 of 130
- Hematology 1.7k
- Genetics 355
- Oncology 793
- Molecular Biology 1.4k
- Cancer Research 221
Countries citing papers authored by Jin Ping Lu
This map shows the geographic impact of Jin Ping Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Ping Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Ping Lu more than expected).
Fields of papers citing papers by Jin Ping Lu
This network shows the impact of papers produced by Jin Ping Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Ping Lu. The network helps show where Jin Ping Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jin Ping Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 172 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis Hit paper breakdown → | 2021 | 448 |
| 2 | 2013 | 278 | |
| 3 | Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer Hit paper breakdown → | 2023 | 256 |
| 4 | 2017 | 226 | |
| 5 | 2011 | 153 | |
| 6 | 2015 | 138 | |
| 7 | 2014 | 93 | |
| 8 | 2020 | 88 | |
| 9 | 2020 | 77 | |
| 10 | 2014 | 77 | |
| 11 | 2016 | 72 | |
| 12 | 2018 | 64 | |
| 13 | 2017 | 53 | |
| 14 | 2017 | 48 | |
| 15 | 2008 | 42 | |
| 16 | 2016 | 41 | |
| 17 | 2017 | 36 | |
| 18 | 2016 | 35 | |
| 19 | 2013 | 33 | |
| 20 | 2019 | 33 |
About Jin Ping Lu
Jin Ping Lu is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Immunology, having authored 172 papers that have together received 3.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (65 papers), Protein Degradation and Inhibitors (18 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (17 papers), Chronic Lymphocytic Leukemia Research (12 papers), Peptidase Inhibition and Analysis (11 papers), Acute Myeloid Leukemia Research (10 papers), Cancer Treatment and Pharmacology (8 papers) and Platelet Disorders and Treatments (8 papers). The work is most often cited by research in Hematology (1.7k citations), Genetics (355 citations), Oncology (793 citations), Molecular Biology (1.4k citations) and Cancer Research (221 citations). Jin Ping Lu has collaborated with scholars based in China, United States and France. Frequent co-authors include Xiao‐Jun Huang, Qian Jiang, Jian Hou, Qing Ge, Wei Chen, Meng Lv, Tao Jiang, Hao Jiang, Dapeng Li and Bo Huang. Their work appears in journals such as Blood, Annals of Hematology, Frontiers in Oncology, BMC Cancer and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.